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the CC BY-NC-ND license (http://creaAbstract Objective: Selective angioembolization (SAE) effectively diagnoses and treats iat-
rogenic vascular complications following percutaneous nephrolithotomy (PCNL).
Methods: We retrospectively reviewed 1329 consecutive PCNLs and identified patients who un-
derwent SAE following PCNL with at least 12-month follow-up. Estimated glomerular filtration
rate (eGFR) was calculated for all patients preoperatively, postoperatively and at last follow-
up. A 1:2 matched cohort analysis was performed.
Results: Twenty-three patients underwent SAE and matched to 46 controls. There was no sta-
tistically significant difference in preoperative, postoperative, and follow-up eGFR when
comparing patients who underwent SAE and those with an uneventful course.
Conclusion: Long-term eGFR is comparable in patients who undergo uncomplicated PCNL and
those requiring SAE.
ª 2017 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Percutaneous nephrolithotomy (PCNL) was first described
by Fernstrom and Johannson [1] in 1976 and is now the
preferred approach for the management of large, complex.edu (Z. Okeke).
f Second Military Medical Univers
.08.012
sian Journal of Urology. Producti
tivecommons.org/licenses/by-nc-renal stones. Despite its routine use in stone centers across
the world, and the less invasive approach when compared
to anotrophic nephrolithotomy, there remains a significant
overall complication rate approaching 20% in contemporary
cohorts [2,3]. Iatrogenic vascular injuries resulting inity.
on and hosting by Elsevier B.V. This is an open access article under
nd/4.0/).
28 R. Palmerola et al.hemorrhage remain a serious complication with approxi-
mately 1%e11% of patients requiring transfusion of blood
products [4e7]. While the majority of patients respond to
conservative measures and recover without incident,
0.48%e2.6% will require selective angioembolization (SAE)
for persistent hemorrhage or hemodynamic instability [8].
Although SAE is an effective procedure to control hemor-
rhage, embolization of a renal arteriole creates areas of
ischemia and subsequent loss of functional parenchyma.
Various authors have published their experience with
vascular complications and attempted to identify potential
risk factors, however the literature regarding the long-term
effects on renal function in patients who underwent PCNL
and required SAE for postoperative hemorrhage is limited.
Furthermore, the studies available have not directly
compared patients who underwent SAE to those who had a
PCNL and did not necessitate SAE. The aim of this study was
to investigate the renal functional outcomes in patients
who underwent PCNL and required SAE, in comparison to
patients who had an uneventful course.2. Methods
After obtaining approval from the Feinstein Institute for
Medical Research Institutional Review Board, we retro-
spectively reviewed 1329 consecutive PCNLs performed
between 2008 and 2015. Patient demographics including
age, gender, weight, body mass index (BMI), comorbidities,
and medication history were identified. Laboratory evalu-
ation included basic metabolic panel (BMP), complete
blood count (CBC), International Normalized Ratio (INR),
urinalysis, and urine culture. Patients were excluded from
analysis if they did not have a serum creatinine measured at
least 12 months postoperatively. Intraoperative and post-
operative details including estimated blood loss (EBL),
operating room time, number of punctures, number of di-
lations, blood product transfusion, and postoperative lab-
oratory studies (CBC, BMP) were collected. All patients had
cross sectional imaging available and images were reviewed
to evaluate stone burden. Those patients who underwent
SAE for postoperative hemorrhage were identified from our
PCNL database. The indications for SAE included clinical
signs of hemorrhagic shock, and failure to respond to con-
servative management (clamping nephrostomy tube, blood
transfusion, intravenous fluid hydration, manual pressure,
etc.). For those patients included in the final analysis
estimated glomerular filtration rate (eGFR) was calculated
using the Cockroft-Gault equation.
A 1:2 matched cohort analysis was performed between
patients who underwent SAE for post PCNL hemorrhage and
those with an uncomplicated postoperative course, adjust-
ing for age, hypertension, and diabetes mellitus. Using
SPSS v23.0 (IBM Corporation, Armonk, New York, USA), a
comparison between the two groups was performed using
Chi-square test for categorical variables and Student’s t-test
for continuous variables. A p < 0.05 was used to determine
statistical significance.
All SAEs were performed by interventional radiology at
our institution. Direct puncture into the femoral artery was
achieved under ultrasound guidance and a 5 Fr vascular
sheath was advanced under fluoroscopic guidance to theabdominal aorta. A microcatheter was then directed into
the renal artery and digital subtraction imaging was per-
formed. Next a 2.8 Fr Progreat microcatheter (Terumo
Medical Corporation, Somerset, New Jersey, USA) was
directed into the injured vessel of interest. A microwire
was then used to direct the microcatheter to the vessel of
interest and detachable coils are deployed. Postemboliza-
tion angiography was performed in all patients and all pa-
tients were observed at least 24 h post procedure.
3. Results
Twenty-three (1.7%) patients underwent SAE and were
matched to 46 patients who had an uneventful post-
operative course. There were no significant differences in
demographic data, operating room time, number of punc-
tures, and tract dilations (Tables 1 and 2). All included
patients in the cohort were managed nonoperatively, and
SAE was effective in controlling hemorrhage. The mean
number of blood transfusions differed between the SAE
group and the control group (3.3% vs. 0.1%, p < 0.001) as
did the EBL (476 mL vs. 162 mL, p < 0.001) and hematocrit
change from baseline to postoperation (10% vs. 5.6%,
p < 0.001). Patients who required postoperative SAE had a
significantly longer length of stay in comparison to matched
controls (9.4 days vs. 3.2 days, p < 0.001) (Table 2). The
mean follow-up in the SAE group and the matched cohort
was 25 months and 18 months, respectively (Table 1). There
was no statistically significant difference in eGFR between
the SAE group and the matched control group in regards to
preoperative eGFR (86.1 vs. 96.1 mL/min/1.73 m2,
p Z 0.432), postoperative eGFR (85.5 vs. 96.4 mL/min/
1.73 m2, p Z 0.424), follow-up eGFR (88.2 vs. 97.6 mL/
min/1.73 m2, p Z 0.423), and change in eGFR between
preoperative and follow-up period (2.1 vs. 1.9 mL/min/
1.73 m2, p Z 0.983) (Table 3).
4. Discussion
Vascular complications following PCNL remain a worrisome
complication, but most cases can be managed conserva-
tively. Vascular injuries are the result of renal artery
branch laceration, which can occur during initial needle
passage for access or tract dilation. In the postoperative
period, patients can present with immediate clinical signs
of hemorrhage including hemodynamic instability (hypo-
tension, shock, tachycardia), anemia, flank pain, and he-
maturia. Furthermore, patients can present in a delayed
fashion (>3 days postoperatively), with new onset gross
hematuria and aforementioned signs of hemorrhage. For
these patients who continue to show signs of hemorrhage
refractory to conservative measures, SAE is an effective
minimally invasive approach to subside post-PCNL hemor-
rhage. The benefits of SAE are well established as it is
effective in treating post-PCNL hemorrhage in up to 88%e
100% of patients with minimal complications secondary to
embolization [5,8,9]. However, SAE effectively embolizes
renal artery branches and thus creates areas of ischemia in
renal parenchyma. Furthermore, the detrimental of effects
of contrast-induced nephropathy must be considered as
well. With the use of modern SAE techniques the area of
Table 1 Baseline patient and disease characteristics.
Characteristic All SAE group Matched group p value
Patientsa 69 (100) 23 (33.33) 46 (66.67) e
Age (year)b 59.9  15.0 59.5  16.3 60.2  14.4 0.857
Gendera 0.862
Male 41 (59.42) 14 (60.87) 27 (58.70)
Female 28 (40.58) 9 (39.13) 19 (41.30)
BMIb 31.9  8.5 29.6  7.9 33.0  8.6 0.115
Comorbiditiesa
Hypertension 48 (69.57) 16 (69.57) 32 (69.57) 1.000
Diabetes mellitus 15 (21.74) 5 (21.74) 10 (21.74) 1.000
Hyperlipidemia 25 (36.23) 6 (26.09) 19 (41.30) 0.215
Coronary artery disease 8 (11.59) 2 (8.70) 6 (13.04) 0.595
Medicationsa
Aspirin 16 (23.19) 4 (17.39) 12 (26.09) 0.245
Clopidogrel 2 (2.90) 1 (4.35) 1 (2.17) 0.701
Coumadin 5 (7.25) 3 (13.04) 2 (4.35) 0.889
Stone sizea 0.008
<2 cm 31 (44.93) 5 (21.74) 26 (56.52)
2 cm 38 (55.07) 18 (78.26) 20 (43.48)
Full staghorna 12 (17.39) 8 (34.78) 4 (8.70) 0.013
Follow-up (month)c 19 (16) 25 (31.5) 18 (14.75) e
BMI, body mass index; IQR, interquartile range; SAE, selective angioembolization.
a Values are presented as n (%).
b Values are presented as mean  SD.
c Values are presented as median (IQR).
Table 2 Perioperative characteristics and complications
(mean  SD).
SAE
group (nZ23)
Matched
group (nZ46)
p value
Length of stay (day) 9.4  6.9 3.2  2.0 <0.001
Operative time (min) 76  48 82  30 0.589
Tract dilations (tract) 1.70  1.02 1.38  0.78 0.209
Punctures (time) 1.83  1.07 1.44  0.88 0.146
EBL (mL) 476  480 162  217 <0.001
Transfusions
(PRBC unit)
3.30  3.05 0.10  0.38 <0.001
Change in
hematocrit (%)
10.1  5.0 5.6  3.9 <0.001
EBL, estimated blood loss; SAE, selective angioembolization.
Table 3 Perioperative and long-term renal function
outcomes (mean  SD).
SAE
group (nZ23)
Matched
group (nZ46)
p value
Preoperative renal function
Creatine (mg/L) 11.4  4.5 12.8  6.9 0.409
eGFR (mL/min/
1.73 m2)
86.1  36.6 96.1  56.8 0.432
Postoperative renal function
Creatine (mg/L) 12.9  8.1 12.8  6.6 0.918
eGFR (mL/min/
1.73 m2)
85.5  40.8 96.4  57.8 0.424
Long-term renal function
Creatine (mg/L) 11.7  5.4 12.3  7.9 0.748
eGFR (mL/min/
1.73 m2)
88.2  42.8 97.6  46.8 0.423
Long-term change in renal function
Creatine (mg/L) 0.2  2.7 0.2  4.8 0.653
eGFR (mL/min/
1.73 m2)
2.1  22.5 1.9  24.0 0.983
eGFR, estimated glomerular filtration rate; SAE, selective
angioembolization.
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the effects on long-term renal function remain unclear.
In our study we found no significant difference in the
eGFR between patients who underwent SAE postoperatively
and controls with an uneventful postoperative course. This
association was maintained from the preoperative period,
postoperatively, and up to the last follow-up. Most reports
investigating the effects of SAE on long-term renal function
were composed of a heterogeneous study population
including patients with renal hemorrhage secondary to
trauma, renal biopsy, and partial nephrectomy. Mohsen
et al. [10] investigated the long-term functional and
morphological effects of SAE by evaluating serum creat-
inine, renal ultrasound, intravenous urography andradionucleotide studies (MAG3 and DMSA scan). After a
mean follow-up of 4.6 years they found that 64% of patients
had solitary photopenic areas on DMSA scan, while 22% had
multiple photopenic areas at 3 months. More importantly,
14% had no evidence of scarring and this number increased
to 21% of the population at last follow-up. Furthermore,
30 R. Palmerola et al.MAG3 scans performed at 3 months and at last follow-up
showed an improvement in GFR from 26 mL/min to
32 mL/min, respectively. Finally, the group found that SAE
was most detrimental for those patients with a solitary
kidney, where four of the nine patients demonstrated an
average increase in creatinine of 3.25 mmol/L. The same
group performed a similar study focusing specifically on
patients undergoing PCNL. Thirty patients in the cohort had
long-term follow-up ranging between 1.9 and 9.2 years [9].
When comparing DMSA scans at 3 months and at last follow-
up, patients with single photopenic areas decreased from
64% to 57% and those with no detectable photopenic areas
increased from 13% to 20%. Similar to their previous study,
patients with a solitary kidney demonstrated the most
pronounced deleterious effects to renal function. Similar to
their prior study, they concluded that renal function and
morphology improves in patients requiring SAE. Our study
differs in that we compared patients who underwent SAE to
a control group with an uneventful postoperative course, as
opposed to observing the effects on renal function with
intervention without a comparable control group. Both of
our study’s cohorts began with comparative renal function
and showed no statistically significant difference in follow-
up. This information becomes important when counseling
patients about the complications of PCNL. Although pa-
tients should be made aware that they may undergo a
second procedure, ultimately their postoperative renal
function and long-term renal function is comparable to
those never suffering a vascular complication. Based on our
results SAE remains an important tool in managing vascular
complications secondary to PCNL.
There are several limitations to this study including the
retrospective nature of the study, small sample size, and
relatively short follow-up. Furthermore, we did not inves-
tigate morphological changes in the kidney following SAE
and did not include stone volume as part of our calculation.
Details regarding the development of hypertension also
would be important in assessing the SAE group in the future.
We believe that the strengths of our study lie in homoge-
neity of the study population in regards to demographics,
numbers of tract dilations and preoperative renal function.
Furthermore we controlled for age, and history of diabetes
or hypertension so that any change in renal function would
be a result of the intervention rather than predisposing
factors. Finally our analysis used the Cockroft-Gault equa-
tion to calculate eGFR, rather than relying on radio-
nucleotide studies as was done in prior studies.5. Conclusion
SAE is an effective tool in controlling bleeding secondary to
a vascular injury sustained during PCNL. Long-term eGFR is
comparable in patients who undergo uncomplicated PCNL
and those that require SAE to control hemorrhage.Conflicts of interest
The authors declare no conflict of interest.References
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